Brazil SUS anemia treatment access lags despite PCDT updates

Brazil's public health system (SUS) has failed to deliver new iron deficiency anemia treatments to patients three years after protocol updates and technology incorporation. Administrative bottlenecks persist despite Ordinance GM/MS No. 4.228, indicating a gap between policy and implementation. This matters for public health outcomes and pharmaceutical market access in Brazil.